ChromaTan Inc.

Enabling flexible and cost-saving manufacturing for life-saving biologic therapies.

  • Stage Prototype Ready
  • Industry Biotechnology
  • Location Philadelphia, PA, USA
  • Currency USD
  • Founded January 2009
  • Employees 11
  • Incorporation Type C-corp
  • Website

Company Summary

Chromatan is commercializing a new purification platform to de-bottleneck large-scale manufacturing of life-saving biologics . We have shown up to 15-fold improvements and 65% cost reduction in multiple pilot studies with large biotechs like Merck and Takeda.

In 2022, ChromaTan was awarded a $2 M Phase IIB SBIR grant from the NIH. We are raising a bridge round of $1 Million for market launch of our process development system in Q4 2022


  • Oleg Shinkazh

    Oleg Shinkazh, founder and CEO of ChromaTan and the inventor of Continuous Countercurrent Tangential Chromatography (CCTC) is a chemical and biotechnologyengineer with 17 years of experience in the biotechnology industry, specializing in downstream processing and purification of biologics. Oleg has been with ChromaTan since October 2009, leading technical and business development of the company.

  • Dr. Andrew Zydney
    Board member

    Dr. Andrew Zydney is a Professor of Chemical Engineering at Penn State University. He is one of the leading researchers in the bioseparations industry, with more than 150 publications in leading industry journals. Dr. Zydney supervises the technical partnership of ChromaTan with Penn State, and has been an invaluable resource for the company.

  • Paul H. Silvis
    Board Member

    Paul founded Restek ( in 1985 to manufacture innovative, high quality chromatography products. The company’s sales exceed $60 Million and continue to outpace competitors. Paul is ChromaTan's largest individual investor and has been an invaluable adviser as a member of the board of directors.

  • Steve Carpenter
    Board Member

    Steve Carpenter is the Vice President of Venture Operations at the Life Sciences Greenhouse of Central Pennsylvania. The LSGPA provides investment and support to promising life sciences companies in central Pennsylvania. Since joining the LSGPA in 2004, Steve has served as a board observer or director for 10 startup companies while evaluating prospective companies for investment.


Previous Investors

  • Ben Franklin of Central PA $500,000
    Life Science Greenhouse of Central PA $600,000
    Series A - Lehigh Valley Angels $215,000
  • Series A - Ben Franklin of Southeastern PA $250,000
    Series A and Notes - $350,000 Sorensen Family Office
    Series A- MRA Realty $160,000

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free